An evaluation of the thyrotrophin-releasing hormone stimulation test in paediatric clinical practice

Area of Science:

• Pediatric Endocrinology
• Clinical Diagnostics
• Hormone Testing

Background:

• Hypothalamic and pituitary dysfunction can significantly impact child development.
• Accurate diagnostic tools are crucial for timely intervention in pediatric endocrine disorders.
• The thyrotropin-releasing hormone (TRH) test has been used to assess pituitary-thyroid axis function.

Purpose of the Study:

• To retrospectively evaluate the clinical utility of the TRH test in children with suspected hypothalamic or pituitary dysfunction.
• To determine if TRH test results correlate with clinical outcomes and guide treatment decisions.
• To assess the TRH test's ability to differentiate between hypothalamic and pituitary disorders.

Main Methods:

• Retrospective review of patient records for children undergoing TRH testing over a 6-year period.
• Categorization into a reference group (no dysfunction) and a study group (suspected insufficiency).
• Analysis of thyrotropin (TSH) and free thyroxine (FT4) levels in relation to TRH test results and clinical diagnoses.

Main Results:

• TRH test results did not reliably distinguish between hypothalamic and pituitary disorders.
• Thyroxine treatment decisions were based on FT4 levels, not TRH test outcomes.
• Subnormal TSH responses were associated with normal FT4, while some normal or exaggerated TRH responses were seen in patients with low FT4.

Conclusions:

• The TRH test provides limited clinical value in diagnosing pediatric hypothalamic or pituitary dysfunction.
• Clinical management relies on direct measurement of FT4 levels.
• The TRH test should be reconsidered and potentially abandoned in pediatric practice due to its lack of utility.